PIK3CD and autism: Analyses of upstream signaling defects and pharmacological rescue experiments using PI3K catalytic subunit-selective inhibitors suggested that increased expression and activity of the PI3K catalytic subunit p110δ, but not p110β, underlie increased S6 phosphorylation and protein synthesis in this autism patient cell line.